Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7101 USD | -4.04% | -8.96% | -77.82% |
May. 22 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
May. 15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 16-12-31 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 17-07-31 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 23-06-19 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 17-07-31 |
Jeffrey Gudin
FOU | Founder | 58 | 16-12-31 |
Director/Board Member | - | 23-03-23 | |
Eric Floyd
CHM | Chairman | 62 | 16-12-31 |
Jerrold Sendrow
BRD | Director/Board Member | 79 | 16-12-31 |
Vanila Singh
BRD | Director/Board Member | 53 | 20-05-31 |
Director/Board Member | 60 | 16-12-31 | |
Michael Dubin
BRD | Director/Board Member | 68 | 21-07-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,108,267 | 1,807,007 ( 85.71 %) | 0 | 85.71 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-77.82% | 832K | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.43% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- VRPX Stock
- Company Virpax Pharmaceuticals, Inc.